223
Views
2
CrossRef citations to date
0
Altmetric
Original Articles: Obstetrics

Maternal serum endothelial cell-specific molecule-1 level and its correlation with severity of early-onset preeclampsia

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon

References

  • [ACOG] ACOG Practice Bulletin No. 202. 2019. Gestational hypertension and preeclampsia. Obstetrics and Gynecology 133:e1–e25.
  • Adekola H, Romero R, Chaemsaithong P, Korzeniewski SJ, Dong Z, Yeo L, et al. 2015. Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes. The Journal of Maternal-Fetal & Neonatal Medicine 28:1621–1632.
  • Aparci M, Isilak Z, Uz O, Yalcin M, Kucuk U. 2015. Endocan and endothelial dysfunction. Angiology 66:488–489.
  • Balta S, Mikhailidis DP, Demirkol S, Ozturk C, Kurtoglu E, Demir M, et al. 2014. Endocan – a novel inflammatory indicator in newly diagnosed patients with hypertension: a pilot study. Angiology 65:773–777.
  • Brosens I, Muter J, Ewington L, Puttemans P, Petraglia F, Brosens JJ, et al. 2019. Adolescent preeclampsia: pathological drivers and clinical prevention. Reproductive Sciences (Thousand Oaks, Calif.) 26:159–171.
  • Chang X, Bian Y, Wu Y, Huang Y, Wang K, Duan T. 2015. Endocan of the maternal placenta tissue is increased in pre-eclampsia. International Journal of Clinical and Experimental Pathology 8:14733–14740.
  • Charolidi N, Host AJ, Ashton S, Tryfonos Z, Leslie K, Thilaganathan B, et al. 2019. First trimester placental endothelial cells from pregnancies with abnormal uterine artery Doppler are more sensitive to apoptotic stimuli. Laboratory Investigation 99:411–420.
  • Chew BS, Ghazali R, Othman H, Ismail NAM, Othman AS, Laim NMST, et al. 2019. Endocan expression in placenta of women with hypertension. Journal of Obstetrics and Gynaecology Research 45:345–351.
  • Eastabrook G, Aksoy T, Bedell S, Penava D, de Vrijer B. 2018. Preeclampsia biomarkers: an assessment of maternal cardiometabolic health. Pregnancy Hypertension 13:204–213.
  • Eddy AC, Bidwell GL, 3rd, George EM. 2018. Pro-angiogenic therapeutics for preeclampsia. Biology of Sex Differences 9:36.
  • Gimbrone MA, Jr, García-Cardeña G. 2016. Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circulation Research 118:620–636.
  • Gooding H, Johnson HM. 2016. The unchartered frontier: preventive cardiology between the ages of 15 and 35 years. Current Cardiovascular Risk Reports 10.
  • Hentschke M, da Cunha Filho E, Vieira M, Paula L, Mistry H, Costa B, et al. 2018. Negative correlation between placental growth factor and endocan-1 in women with preeclampsia. Revista Brasileira de Ginecologia e Obstetrícia/RBGO Gynecology and Obstetrics 40:593–598.
  • Herraiz I, Llurba E, Verlohren S, Galindo A. 2018. Update on the diagnosis and prognosis of preeclampsia with the aid of the sFlt-1/PlGF ratio in singleton pregnancies. Fetal Diagnosis and Therapy 43:81–89.
  • Hooijschuur MCE, Ghossein-Doha C, Kroon AA, De Leeuw PW, Zandbergen AAM, Van Kuijk SMJ, et al. 2019. Metabolic syndrome and pre-eclampsia. Ultrasound in Obstetrics & Gynecology 54:64–71.
  • Kachur S, Lavie CJ, de Schutter A, Milani RV, Ventura HO. 2017. Obesity and cardiovascular diseases. Minerva Medica 108:212–228.
  • Köninger A, Enekwe A, Mach P, Andrikos D, Schmidt B, Frank M, et al. 2018. Afamin: an early predictor of preeclampsia. Archives of Gynecology and Obstetrics 298:1009–1016.
  • Powe CE, Levine RJ, Karumanchi SA. 2011. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation 123:2856–2869.
  • Purde M-T, Baumann M, Wiedemann U, Nydegger UE, Risch L, Surbek D, et al. 2015. Incidence of preeclampsia in pregnant Swiss women. Swiss Medical Weekly 145:w14175.
  • Roudnicky F, Poyet C, Wild P, Krampitz S, Negrini F, Huggenberger R, et al. 2013. Endocan is upregulated on tumor vessels in invasive bladder cancer where it mediates VEGF-A-induced angiogenesis. Cancer Research 73:1097–1106.
  • Sarrazin S, Adam E, Lyon M, Depontieu F, Motte V, Landolfi C, et al. 2006. Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy. Biochimica et Biophysica Acta 1765:25–37.
  • Schuitemaker JHN, Cremers TIFH, Van Pampus MG, Scherjon SA, Faas MM. 2018. Changes in endothelial cell specific molecule 1 plasma levels during preeclamptic pregnancies compared to healthy pregnancies. Pregnancy Hypertension 12:58–64.
  • Sibai BM, el-Nazer A, Gonzalez-Ruiz A. 1986. Severe preeclampsia–eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis. American Journal of Obstetrics and Gynecology 155:1011–1016.
  • Stanek J. 2019. Histological features of shallow placental implantation unify early-onset and late-onset preeclampsia. Pediatric and Developmental Pathology 22:112–122.
  • Szpera-Goździewicz A, Kosicka K, Goździewicz T, Krzyścin M, Wirstlein P, Siemiątkowska A, et al. 2020. Serum endocan concentration and its correlation with severity of hypertensive disorders in pregnancy. The Journal of Maternal-Fetal & Neonatal Medicine 33:2313–2317.
  • Topçu HO, Güzel Aİ, Ozgü E, Yıldız Y, Erkaya S, Uygur D. 2014. Birth weight for gestational age: a reference study in a tertiary referral hospital in the middle region of Turkey. Journal of the Chinese Medical Association: JCMA 77:578–582.
  • Yuksel MA, Tuten A, Oncul M, Acikgoz AS, Temel Yuksel I, Toprak MS, et al. 2015. Serum endocan concentration in women with pre-eclampsia. Archives of Gynecology and Obstetrics 292:69–73.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.